Data from EMC - Curated by Toby Galbraith - Last updated 18 May 2017

Licensing authority

EMA (European Medicines Agency)

Indication(s)

Prevention of premature ovulation in patients undergoing a controlled ovarian stimulation, followed by oocyte pick-up and assisted reproductive techniques.

In clinical trials Cetrotide was used with human menopausal gonadotropin (HMG), however, limited experience with recombinant follicule-stimulating hormone (FSH) suggested similar efficacy.

Full Prescribing information

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Acute and Advanced Heart Failure

What are the most effective treatments for acute heart failure? Can you define advanced heart failure? Discover here...

Visit Acute and Advanced Heart Failure

Hypogonadism

Epidemiology, pathophysiology, diagnosis/treatment guidelines, recent publication summaries and more

Visit Hypogonadism

More information

Category Value
Agency product number EMEA/H/C/000233
Orphan designation No
Date First Approved 13-04-1999
Type Medicinal product subject to medical prescription
Marketing authorisation holder Merck Serono Europe Ltd.

Related Content